CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
54.40
6.85%
Market Trading Hours* (UTC) Opens on Wednesday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.35
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 5%
Stock exchange France
Commission on trade 0%

*Information provided by Capital.com

Eurofins Scientific SE ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 58.4
Open* 52.9
1-Year Change* -21.46%
Day's Range* 51.3 - 54.6
52 wk Range 44.83-72.12
Average Volume (10 days) 249.16K
Average Volume (3 months) 6.97M
Market Cap 10.75B
P/E Ratio 21.47
Shares Outstanding 192.19M
Revenue 6.51B
EPS 2.59
Dividend (Yield %) 1.79598
Beta 0.40
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 26, 2024 58.40 0.80 1.39% 57.60 58.65 57.40
Feb 23, 2024 57.90 0.75 1.31% 57.15 58.10 57.15
Feb 22, 2024 57.40 -0.30 -0.52% 57.70 58.25 57.25
Feb 21, 2024 57.30 0.60 1.06% 56.70 57.90 56.70
Feb 20, 2024 57.60 0.30 0.52% 57.30 57.85 57.10
Feb 19, 2024 57.60 0.50 0.88% 57.10 57.65 56.80
Feb 16, 2024 57.65 2.30 4.16% 55.35 57.90 55.30
Feb 15, 2024 55.30 0.15 0.27% 55.15 55.65 55.10
Feb 14, 2024 54.95 1.20 2.23% 53.75 55.05 53.75
Feb 13, 2024 54.15 0.20 0.37% 53.95 54.85 53.55
Feb 12, 2024 53.90 -0.05 -0.09% 53.95 54.50 53.75
Feb 9, 2024 53.85 0.00 0.00% 53.85 54.20 53.55
Feb 8, 2024 54.10 0.35 0.65% 53.75 54.80 53.75
Feb 7, 2024 54.00 0.10 0.19% 53.90 54.70 53.65
Feb 6, 2024 53.65 0.10 0.19% 53.55 53.85 52.85
Feb 5, 2024 53.45 0.10 0.19% 53.35 53.80 53.25
Feb 2, 2024 53.40 -1.00 -1.84% 54.40 54.95 53.35
Feb 1, 2024 54.05 -1.25 -2.26% 55.30 55.45 54.05
Jan 31, 2024 55.90 0.10 0.18% 55.80 56.20 55.65
Jan 30, 2024 55.90 -0.65 -1.15% 56.55 56.95 55.75

Eurofins Scientific Events

Time (UTC) Country Event
Wednesday, April 24, 2024

Time (UTC)

05:15

Country

LU

Event

Q1 2024 Eurofins Scientific SE Trading Statement Release
Q1 2024 Eurofins Scientific SE Trading Statement Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 6712.1 6717.7 5438.8 4562.8 3781.15
Revenue 6712.1 6717.7 5438.8 4562.8 3781.15
Cost of Revenue, Total 5199.1 4816 4026.1 3632.1 3061.3
Gross Profit 1513 1901.7 1412.7 930.7 719.845
Total Operating Expense 5675.2 5244.9 4415.2 3989.3 3260.39
Selling/General/Admin. Expenses, Total 0 0 0
Depreciation / Amortization 476 428.9 389.1 357.2 199.085
Other Operating Expenses, Total 0.1
Operating Income 1036.9 1472.8 1023.6 573.5 520.76
Interest Income (Expense), Net Non-Operating -120.9 -97 -97.5 -93.2 -59.717
Other, Net -12.3 -7 -5.9 -3.1 -0.001
Net Income Before Taxes 903.7 1368.8 920.2 477.2 461.042
Net Income After Taxes 683 1043.4 707.2 360.3 356.061
Minority Interest 4.4 -0.4 -1 0 0.358
Net Income Before Extra. Items 687.4 1043 706.2 360.3 356.419
Total Extraordinary Items -77.3 -260 -166.7 -165 -132.476
Net Income 610.1 783 539.5 195.3 223.943
Total Adjustments to Net Income -29.2 -34.5 -34.2 -49.8 -48.624
Income Available to Common Excl. Extra. Items 658.2 1008.5 672 310.5 307.795
Income Available to Common Incl. Extra. Items 580.9 748.5 505.3 145.5 175.319
Dilution Adjustment 0
Diluted Net Income 580.9 748.5 505.3 145.5 175.319
Diluted Weighted Average Shares 199 200.6 195.9 186 183.01
Diluted EPS Excluding Extraordinary Items 3.30754 5.02742 3.43032 1.66935 1.68185
Dividends per Share - Common Stock Primary Issue 1 1 0.68 0 0.288
Diluted Normalized EPS 3.51224 5.02742 3.43032 1.66935 1.68185
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 3209.5 3300.6 3411.5 3445.4 3272.3
Revenue 3209.5 3300.6 3411.5 3445.4 3272.3
Cost of Revenue, Total 2569.9 2616.8 2582.3 2551.8 2264.2
Gross Profit 639.6 683.8 829.2 893.6 1008.1
Total Operating Expense 2813 2865.5 2809.7 2785.9 2459
Selling/General/Admin. Expenses, Total 0 0 0 0 0
Depreciation / Amortization 243 248.6 227.4 234.1 194.8
Operating Income 396.5 435.1 601.8 659.5 813.3
Interest Income (Expense), Net Non-Operating -42.3 -63.4 -69.8 -54.4 -49.6
Net Income Before Taxes 354.3 371.7 532 605.1 763.7
Net Income After Taxes 261 287.2 395.8 460.5 582.9
Minority Interest 0.8 2.7 1.7 0 -0.4
Net Income Before Extra. Items 261.8 289.9 397.5 460.5 582.5
Total Extraordinary Items -110.3 10.5 -87.8 -93.1 -166.9
Net Income 151.5 300.4 309.7 367.4 415.6
Total Adjustments to Net Income -26.8 -11.2 -18 -16.3 -18.2
Income Available to Common Excl. Extra. Items 235 278.7 379.5 444.2 564.3
Income Available to Common Incl. Extra. Items 124.7 289.2 291.7 351.1 397.4
Diluted Net Income 124.7 289.2 291.7 351.1 397.4
Diluted Weighted Average Shares 198.2 198 200 200.2 201
Diluted EPS Excluding Extraordinary Items 1.18567 1.40758 1.8975 2.21878 2.80746
Dividends per Share - Common Stock Primary Issue 0 1 0 1 0
Diluted Normalized EPS 1.23027 1.55977 1.8975 2.21878 2.80746
Other Operating Expenses, Total 0.1 0.1
Other, Net 0.1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 2313.3 2319 2518.2 1604.1 1705.4
Cash and Short Term Investments 486.6 515.3 912.4 297 506.246
Cash 432.2 497.9 903.7 293.4 24.599
Cash & Equivalents 54.4 17.4 8.7 3.6 481.647
Total Receivables, Net 1597.3 1581 1389.1 1185 1043.32
Accounts Receivable - Trade, Net 1341.7 1389.2 1193.5 1001.2 807.233
Total Inventory 145.6 154.2 157 79.3 66.373
Prepaid Expenses 78.3 68 59.6 42.6 42.668
Other Current Assets, Total 5.5 0.5 0.1 0.2 46.796
Total Assets 10083.5 9332.3 8575.5 7823.1 7205.45
Property/Plant/Equipment, Total - Net 2167.7 1829.9 1574.9 1593.5 1018.01
Property/Plant/Equipment, Total - Gross 4736.7 4020.7 3344.9 3171.5 2151.32
Accumulated Depreciation, Total -2569.1 -2190.8 -1769.9 -1578 -1133.31
Goodwill, Net 4524.1 4115.1 3524.1 3608.8 3418.33
Intangibles, Net 919.1 895.7 825.1 918.2 946.918
Long Term Investments 83.6 81.7 56.6 54.5 72.626
Other Long Term Assets, Total 75.7 90.9 76.6 44 44.169
Total Current Liabilities 1772.2 1855.7 1696.4 1581.6 1450.66
Payable/Accrued -0.1
Accrued Expenses 843.7 874.6 796.6 623.7 560.803
Notes Payable/Short Term Debt 78.4 80.3 16.9 319.5 372.243
Current Port. of LT Debt/Capital Leases 135.4 173.5 220.7 135.3 18.832
Other Current Liabilities, Total 367.3 404.4 383.4 271.6 266.84
Total Liabilities 5301.4 4684.6 4885.2 4984.5 4536.26
Total Long Term Debt 3111.8 2500.3 2917.2 3086.9 2766.17
Long Term Debt 2712.8 2082.1 2502.4 2646.8 2727.22
Capital Lease Obligations 399 418.2 414.8 440.1 38.946
Deferred Income Tax 133.6 123.6 115.3 124.5 138.557
Minority Interest 68.9 29.5 26.1 59.5 52.992
Other Liabilities, Total 214.9 175.5 130.2 132 127.88
Total Equity 4782.1 4647.7 3690.3 2838.6 2669.19
Common Stock 1.9 1.9 1.9 1.8 1.775
Retained Earnings (Accumulated Deficit) 3925.9 3542.7 2853.1 1697.1 1614.03
Other Equity, Total 868.5 1106.7 835.3 1139.9 1053.57
Total Liabilities & Shareholders’ Equity 10083.5 9332.3 8575.5 7823.1 7205.45
Total Common Shares Outstanding 192.52 192.214 190.794 179.035 177.522
Accounts Payable 347.4 322.9 278.9 231.5 231.942
Treasury Stock - Common -14.2 -3.6 0 -0.2 -0.184
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 2584.9 2313.3 2706.7 2319 2412.9
Cash and Short Term Investments 686.4 486.6 718.8 515.3 639.9
Cash & Equivalents 686.4 486.6 718.8 515.3 639.9
Total Receivables, Net 1504.2 1477.3 1594.3 1465.9 1405.3
Accounts Receivable - Trade, Net 1356.3 1341.7 1471.5 1389.2 1316
Total Inventory 150.3 145.6 159.2 154.2 169.1
Prepaid Expenses 237.6 198.3 231.7 183.1 198.4
Other Current Assets, Total 6.4 5.5 2.7 0.5 0.2
Total Assets 10317.9 10083.5 10260.8 9332.3 8661
Property/Plant/Equipment, Total - Net 2207.1 2167.7 1975.6 1829.9 1667.3
Goodwill, Net 4519.7 4524.1 4453.6 4115.1 3643.3
Intangibles, Net 853.3 919.1 971.1 895.7 814.9
Long Term Investments 80.4 83.6 82.7 81.7 61.5
Other Long Term Assets, Total 72.5 75.7 71.1 90.9 61.1
Total Current Liabilities 1801.8 1772.2 2032.1 1855.7 1758.1
Payable/Accrued 564.8 647.7 590.3 627.6 530.8
Accrued Expenses 77.6 38 39.3 31.4 44.4
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 145.7 213.8 261.3 253.8 128.2
Other Current Liabilities, Total 1013.7 872.7 1141.2 942.9 1054.7
Total Liabilities 5317.7 5301.4 5563.3 4684.6 4581.8
Total Long Term Debt 3128.9 3111.8 3084.5 2500.3 2526.8
Long Term Debt 3128.9 3111.8 3084.5 2500.3 2526.8
Deferred Income Tax 128.8 133.6 162.4 123.6 116.2
Minority Interest 67.5 68.9 69.8 29.5 31
Other Liabilities, Total 190.7 214.9 214.5 175.5 149.7
Total Equity 5000.2 4782.1 4697.5 4647.7 4079.2
Common Stock 1.9 1.9 1.9 1.9 1.9
Retained Earnings (Accumulated Deficit) 3861.2 3925.9 3613.4 3542.7 3132.2
Other Equity, Total 1184.7 868.5 1094 1106.7 945.1
Total Liabilities & Shareholders’ Equity 10317.9 10083.5 10260.8 9332.3 8661
Total Common Shares Outstanding 192.191 192.52 192.338 192.214 191.329
Treasury Stock - Common -47.6 -14.2 -11.8 -3.6
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 780 1056.6 694.4 271.5 289.84
Cash From Operating Activities 1136.2 1511.5 1223.5 677.8 543.894
Cash From Operating Activities 504.4 450.7 426 395.9 223.747
Non-Cash Items 12.2 227.4 142.8 69.6 41.124
Cash Taxes Paid 296.1 296.7 94 95 67.816
Cash Interest Paid 49.4 168.8 67.8 93.3 59.983
Changes in Working Capital -264.9 -315.1 -142.5 -159.2 -88.622
Cash From Investing Activities -855.9 -1021 -525 -540.2 -1557.45
Capital Expenditures -660.2 -506.4 -355.5 -425.1 -364.449
Other Investing Cash Flow Items, Total -195.7 -514.6 -169.5 -115.1 -1193
Cash From Financing Activities -311.3 -910.3 -48.6 -342.2 691.064
Financing Cash Flow Items -502.9 -205.6 -104.5 -461.9 -108.706
Total Cash Dividends Paid -192.1 -129.8 -51.1 -42.645
Issuance (Retirement) of Stock, Net -1.2 32.2 564.8 23.4 20.041
Issuance (Retirement) of Debt, Net 384.9 -607.1 -508.9 147.4 822.374
Foreign Exchange Effects -0.8 24.3 -33.9 4.1 1.465
Net Change in Cash -31.8 -395.5 616 -200.5 -321.023
Amortization 104.5 91.9 102.8 100 77.805
Dec 2022 Jun 2022 Dec 2021 Jun 2021
Net income/Starting Line 780 423.9 1056.6 578.8
Cash From Operating Activities 1136.2 468.1 1511.5 708.6
Cash From Operating Activities 504.4 240 450.7 204.4
Non-Cash Items 116.7 86.6 319.3 192.8
Cash Taxes Paid 296.1 179.4 296.7 139.9
Cash Interest Paid 49.4 14.5 168.8 135.8
Changes in Working Capital -264.9 -282.4 -315.1 -267.4
Cash From Investing Activities -855.9 -474.6 -1021 -276.5
Capital Expenditures -660.2 -289.5 -506.4 -223
Other Investing Cash Flow Items, Total -195.7 -185.1 -514.6 -53.5
Cash From Financing Activities -311.3 168.2 -910.3 -718.7
Financing Cash Flow Items -502.9 -342.2 -205.6 -150.4
Total Cash Dividends Paid -192.1 -129.8 -0.4
Issuance (Retirement) of Stock, Net -1.2 -0.3 32.2 12.6
Issuance (Retirement) of Debt, Net 384.9 510.7 -607.1 -580.5
Foreign Exchange Effects -0.8 39.3 24.3 14.7
Net Change in Cash -31.8 201 -395.5 -271.9
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Gilles Martin Family Other Insider Investor 32.7494 63145480 0 2022-12-31 LOW
Capital Research Global Investors Investment Advisor 3.7631 7255754 -28640 2023-09-30 LOW
Mawer Investment Management Ltd. Investment Advisor 2.1554 4155960 181 2023-09-30 LOW
Harris Associates L.P. Investment Advisor/Hedge Fund 2.0657 3982980 1500 2023-08-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 1.8484 3563974 -26765 2023-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.843 3553655 14287 2023-09-30 LOW
RBC Global Asset Management (UK) Limited Investment Advisor 1.55 2988597 -59239 2023-09-30 LOW
Allianz Global Investors GmbH Investment Advisor 1.5448 2978558 1799 2023-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4545 2804489 130325 2022-12-31 LOW
Impax Asset Management Ltd. Investment Advisor 1.387 2674365 -41320 2023-09-30 LOW
Ruane, Cunniff & Goldfarb L.P. Investment Advisor 1.3247 2554212 0 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.2441 2398807 -18865 2023-09-30 LOW
1832 Asset Management L.P. Investment Advisor 1.1724 2260619 -15191 2023-06-30 LOW
Capital World Investors Investment Advisor 0.9485 1828875 -383 2023-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.9294 1792049 -274576 2023-08-31 LOW
Jupiter Asset Management Ltd. Investment Advisor/Hedge Fund 0.7218 1391753 -82479 2023-06-30 LOW
Credit Suisse Funds AG Investment Advisor/Hedge Fund 0.6892 1328915 -2050 2023-09-30 LOW
T. Rowe Price International Ltd Investment Advisor/Hedge Fund 0.5307 1023321 -17749 2023-09-30 LOW
BNP Paribas Asset Management France SAS Investment Advisor/Hedge Fund 0.5249 1012124 994097 2023-09-30 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.4816 928571 8142 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Eurofins Company profile

Eurofins Scientific is an international laboratory testing company, founded in 1987 and headquartered in Luxembourg. Through its subsidiaries, the company offers environmental, pharmaceutical products and food testing, as well as the key emerging specialty clinical diagnostic testing.

The company prides itself on performing over 400 million tests each year and holding over 200,000 validated analytical methods in its portfolio. With over 45,000 employees, Eurofins Scientific operates a global network of 800 laboratories in 47 countries.

Eurofins operates through an extensive network of laboratories, including Institut Nehring GmbH in Germany, VRL Laboratories in the United States, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. Eurofins also have subsidiaries in Eastern Canada, Brazil, and Japan.

One of the fastest-growing companies in Europe, Eurofins Scientific is known for its aggressive expansion strategy, as it has bought more than 80% of its competitors worldwide. Since it went public in 1997 on the French stock exchange, Eurofins has been reporting a 35% growth in sales each year with 3.7 billion Euro in 2018.

The Eurofins share price is quoted on Euronext Paris and featured in the CAC Mid 60 Index. Find out an updated Eurofins company profile, the latest company news and the most current Eurofins share price data at Capital.com.

Industry: Healthcare Facilities & Services (NEC)

23 Val Fleuri
LUXEMBOURG
1526
LU

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Gold

2,029.89 Price
-0.070% 1D Chg, %
Long position overnight fee -0.0189%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

57,007.40 Price
+4.210% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

17,966.50 Price
+0.360% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.59 Price
+5.750% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading